Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Published on by Forensic Scientist

Assoc. Prof. Dr. Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Izmir Katip Çelebi University Atatürk Training and Research Hospital | Turkey

Dr. Tuncay Kırış, an Associate Professor at İzmir Kâtip Çelebi University, Izmir, Turkey, is a distinguished cardiology researcher recognized for his extensive contributions to cardiovascular medicine, particularly in the fields of cardiovascular risk prediction, interventional cardiology, acute coronary syndromes, and cardiac biomarkers. His research has provided valuable insights into myocardial infarction, pulmonary embolism, renal complications following cardiac interventions, and the prognostic implications of biochemical and hematological markers in predicting patient outcomes. Dr. Tuncay Kırış has authored 83 peer-reviewed publications in prestigious international journals indexed in SCI and SCI-Expanded, including Angiology, BMC Cardiovascular Disorders, The Anatolian Journal of Cardiology, Clinical and Experimental Hypertension, Herz, and Acta Radiologica. His works have received 591 citations from 544 documents, with an h-index of 15, according to Scopus (Author ID: 55321350600), reflecting his strong academic impact. His studies emphasize innovative predictive and prognostic modeling approaches, such as exploring the fibrinogen-to-albumin ratio, red cell distribution width, and lymphocyte-to-monocyte ratio as novel indicators of adverse cardiovascular events and renal complications. Beyond his research, he has supervised postgraduate theses on cardiovascular risk assessment, contributed to collaborative projects in clinical and translational cardiology, and serves as Editor of the Ege Klinikleri Tıp Dergisi. As an active reviewer for several international cardiology journals, Dr. Tuncay Kırış continues to advance evidence-based cardiology through data-driven research, bridging clinical practice with innovation to improve patient outcomes and global cardiovascular health.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  • Yildirim, S. E., Yildirim, T., Kırış, T., & Avci, E. (2025, October). Prognostic value of the NAPLES score and serum uric acid in chronic coronary syndrome: Evidence from time-dependent ROC and time-varying hazard ratio analyses. Journal of Clinical Medicine, 14(20), 7416. https://doi.org/10.3390/jcm14207416

  • Tiryaki, M. M., Yılmaz, C., Ince, H. S., Karaca, B., Kayaalti Esin, F., & Kırış, T. (2025, September). Neutrophil percentage-to-albumin ratio as a predictor of in-hospital mortality in infective endocarditis. Biomarkers in Medicine, 19(17), 1–8. https://doi.org/10.1080/17520363.2025.2562554

  • Akkan, G., Kırış, T., Esin, F., & Karaca, M. (2025, May). Evaluation of mortality and hospitalization due to decompensated heart failure and appropriate shocks in reduced ejection fraction in patients with an implantable cardioverter–defibrillator according to a novel tissue Doppler echocardiographic method. Journal of Clinical Medicine, 14(9), 3226. https://doi.org/10.3390/jcm14093226

  • Esin, F., Bozkurt, H., Palac, B., Akar, B., Kırış, T., Özdemir, E., & Karaca, M. (2025, February). The impact of pleural effusion on long-term mortality in patients undergoing transcatheter aortic valve implantation. Journal of Clinical Medicine, 14(5), 1596. https://doi.org/10.3390/jcm14051596

  • Usta, A., Sancakli Usta, C., Lafci, D., Kırış, T., & Avci, E. (2024, December). Contrast induced nephropathy in women with infertility undergoing hysterosalpingography. Reproductive Biology and Endocrinology, 22(1). https://doi.org/10.1186/s12958-024-01334-3

Chunmei Qin | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist

Dr. Chunmei Qin | Medicine and Health Sciences | Best Researcher Award

Luzhou People’s Hospital | China

Dr. Chunmei Qin is a highly respected nephrologist and Director at Luzhou People’s Hospital. With over a decade of dedicated experience in clinical practice, research, and academic mentoring, she has played a pivotal role in advancing nephrology care in China. Her scientific acumen and leadership have led her to spearhead more than ten provincial and municipal research initiatives, gaining national recognition for her innovative contributions. As a recipient of multiple prestigious honors, she exemplifies clinical excellence blended with research-driven impact.

Author Profile👤

Scopus

Strengths for the Awards✨

Dr. Chunmei Qin brings over a decade of comprehensive clinical, academic, and research experience in nephrology, making her a competitive candidate for the Best Researcher Award. She has led or participated in 10+ provincial and municipal-level research projects, including those funded by the Luzhou Medical Association, Sichuan Province Medical Research Project Plan, and Luzhou Science and Technology Program. Notably, one of her research outcomes has been recognized as nationally advanced.

She has authored five peer-reviewed articles in respected SCI-indexed journals, with research that spans from kidney failure in diabetic nephropathy patients to oxidative stress mechanisms in diabetic kidney disease. These works contribute meaningfully to both clinical practice and academic discourse. Additionally, she has received multiple accolades, including:

  • Outstanding Young Paper Award by the Sichuan Medical Association.

  • Outstanding Contribution Award by the Municipal Health Commission.

Her active engagement in professional organizations and committees (such as the Nephropathy Branch of the Sichuan Medical Promotion Association) further reinforces her leadership in the field.

🎓 Education

Dr. Qin holds a strong academic foundation in nephrology, built through extensive medical training and continuous professional development. Her academic journey is characterized by a focus on integrating clinical insights with evidence-based research, equipping her with the analytical skills and expertise required to navigate complex patient cases and contribute to impactful studies.

🏥 Experience

Currently serving as Director at Luzhou People’s Hospital, Dr. Qin has amassed significant experience across clinical care, research, and medical education. Her responsibilities encompass managing nephrology units, mentoring junior physicians, and leading interdisciplinary teams in patient-centered care. Her experience extends beyond the bedside to include policymaking contributions at the municipal level through health commissions.

🔬 Research Interests On Medicine and Health Sciences

Dr. Qin’s research interests lie primarily in nephrology, with a special focus on diabetic kidney disease, chronic kidney failure, oxidative stress mechanisms, and the psychological implications of kidney disease. She is passionate about exploring the intersection between metabolic disorders and renal complications, as well as applying molecular approaches to improve patient outcomes.

🏆 Awards

Dr. Qin has received multiple accolades in recognition of her outstanding contributions. These include the Outstanding Young Paper Award from the Sichuan Medical Association and the Outstanding Contribution Award from the Municipal Health Commission. Her work, acknowledged both locally and nationally, reflects her commitment to excellence in nephrology research and healthcare delivery.

📄 Publications

Dr. Qin has authored several impactful studies in internationally recognized SCI journals, demonstrating both breadth and depth in her research:

  1. Qin, C., Wu, Y., Zou, Y., et al. Associations between depressive and anxiety symptoms and incident kidney failure in patients with diabetic nephropathy, BMC Nephrology, 2025; 26:54. Cited by multiple nephrology scholars for its clinical relevance.

  2. Qin, C., Wang, Y., Zhao, L., et al. Clinical and pathological features of Chinese patients with type 2 diabetes, biopsy-proven diabetic kidney disease, and rapid eGFR decline, Diabetes Metab Syndr Obes, 2022; 15:2847–2856. Widely cited for advancing understanding of kidney function trajectories.

  3. Qin, C., Yin, D., Liu, F., et al. Thrombotic thrombocytopenic purpura in a patient on long-term alpha-interferon therapy: a case report, BMC Nephrology, 2023; 24(1):143. Referenced in case studies on rare renal pathologies.

  4. Zhang, R., Qin, C., Zhang, J., et al. DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/P66shc pathway in diabetic kidney disease, FASEB Journal, 2024; 38(6):e23564. Significantly cited in molecular nephrology and oxidative stress research.

  5. Qin, C., Li, G., Yuan, Y., et al. Association between uric acid to HDL-C ratio and diabetic kidney disease in US adults, Scientific Reports, 2025; 15:24353. Cited for its epidemiological insights on metabolic markers.

Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Published on by Forensic Scientist

Dr. Andrew Vyse | Medicine | Excellence Award (Any Scientific field)

Epidemiologist | Pfizer UK Ltd | United Kingdom

Dr. Andrew Vyse is a seasoned epidemiologist with extensive experience in both the pharmaceutical industry and public health research. He specializes in vaccine-preventable and potentially vaccine-preventable infections, contributing significantly to the field with over 80 peer-reviewed publications.

Profile

Scopus

Strengths for the Awards

  • Prolific Research Contributions:
    • Dr. Vyse has authored over 80 peer-reviewed publications, which demonstrates a consistent and significant contribution to epidemiological research, particularly in the area of vaccine-preventable diseases.
    • Recent publications cover diverse, critical topics such as Lyme disease, pneumococcal vaccination, RSV, and cost-effectiveness of vaccine strategies. This breadth indicates a comprehensive understanding of the field.
  • Impact on Public Health:
    • His work in vaccine-preventable diseases directly contributes to public health improvements, including informing vaccination strategies and addressing vaccine-preventable hospitalizations.
  • Industry and Academic Experience:
    • A balance of pharmaceutical industry experience (Pfizer and GSK) and public health research (UKHSA) highlights his ability to bridge scientific research with practical applications.
    • This unique positioning allows him to contribute to both policy-making and the development of new vaccine technologies.

Education 🎓

Dr. Vyse holds a PhD and MSc, reflecting his robust academic foundation in epidemiology and public health. His educational background has equipped him with the expertise to drive impactful research and clinical applications in his field.

Professional Experience 💼

  • Feb 2017 – Present: Clinical Epidemiologist at Pfizer UK Ltd, supporting the UK Medical Team and global Scientific Affairs for vaccines including pneumococcal, RSV, COVID, meningococcal, and a candidate Lyme vaccine.
  • Jan 2009 – Jan 2017: Global Epidemiologist at GSK Vaccines, contributing to portfolios for meningococcal, DTP, and rotavirus vaccines.
  • May 1993 – Dec 2008: Clinical Scientist at the UK Health Security Agency (formerly Public Health England), focusing on surveillance and epidemiological research for vaccine-preventable infections.

Research Interests On Medicine 🧬

Dr. Vyse’s research interests revolve around vaccine-preventable diseases, with a particular focus on respiratory infections, Lyme borreliosis, and strategies to optimize vaccination coverage in vulnerable populations.

Awards and Recognition 🏆

Dr. Vyse has been recognized for his contributions to epidemiology and vaccine research. His work has garnered significant academic and industry accolades, reflecting his impact on public health initiatives and vaccine development.

Publications 🔖

1. Estimating adult accident and emergency attendances in English hospitals attributed to respiratory syncytial virus

  • Authors: Vyse, A., Wright, H., Begier, E.
  • Year: 2024
  • Citations: 0

2. Using Catalytic Models to Interpret Age-Stratified Lyme Borreliosis Seroprevalence Data

  • Authors: Vyse, A., Colby, E.
  • Year: 2024
  • Citations: 0

3. Incidence of symptomatic Lyme borreliosis in nine European countries

  • Authors: Angulo, F.J., Colby, E., Lebech, A.-M., Moïsi, J.C., Stark, J.H.
  • Year: 2024
  • Citations: 1

4. Adult risk groups for vaccine-preventable respiratory infections: an overview of the UK environment

  • Authors: Reynard, C., Campling, J., Gordon, A.L., Wright, H., Ellsbury, G.
  • Year: 2024
  • Citations: 0

5. Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom

  • Authors: Wilson, M., Lucas, A., Mendes, D., Ellsbury, G.F., Perdrizet, J.
  • Year: 2023
  • Citations: 9

6. Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK

  • Authors: Schley, K., Kowalik, J.C., Sullivan, S.M., Tichy, E., Findlow, J.
  • Year: 2023
  • Citations: 0

7. Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?

  • Authors: Neri, M., Brassel, S., Schirrmacher, H., Steuten, L., Hamson, E.
  • Year: 2023
  • Citations: 4

8. A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019

  • Authors: Paradowska-Stankiewicz, I., Zbrzezniak, J., Skufca, J., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 5

9. Incidence of Lyme Borreliosis in Germany

  • Authors: Skufca, J., Tran, T.M.P., Brestrich, G., Gessner, B.D., Stark, J.H.
  • Year: 2023
  • Citations: 2

10. Incidence of Lyme Borreliosis in the Dutch General Practice Population

  • Authors: Houben, E., De Jong, H., Penning-Van Beest, F., Herings, R., Stark, J.H.
  • Year: 2023
  • Citations: 3

Conclusion 🌐

Dr. Andrew Vyse’s work bridges the pharmaceutical industry and public health research, driving innovations in vaccine development and disease prevention. His dedication to epidemiology continues to advance global health outcomes, underpinned by his extensive research, impactful publications, and commitment to public health initiatives.

Tadeusz Dobosz | Molecular Medicine | Best Researcher Award

Published on by Forensic Scientist

Prof. Tadeusz Dobosz | Molecular Medicine | Best Researcher Award

Retired | University of Medicine Wroclaw | Poland

Tadeusz Dobosz, is a distinguished medical scientist and forensic geneticist. Married with two children, he has made significant contributions to the fields of molecular biology, medical genetics, and forensic science. A retired professor, Dobosz is known for his expertise in DNA technologies, paternity testing, and seroanthropology. He has authored over 75 publications on the Philadelphia List, 515 additional papers, and oral presentations with a Hirsch Index of 20. Currently, he is focused on developing a Museum of Medicine.

Profile

Scopus

Orcid

Strenghts for the Awards

  1. Extensive Academic and Professional Experience:
    • Over 49 years of professional engagement in biochemistry, molecular biology, forensic genetics, and medical genetics.
    • Progression from Assistant to University Professor and Head of the Molecular Techniques Unit at the Medical University of Wrocław.
    • Leadership roles in establishing and managing research laboratories, including Molecular Medicine, Paternity Testing, Forensic Genetics, and Seroanthropology.
  2. Research Contributions:
    • Authored 75 publications indexed in the Philadelphia List and over 515 additional papers, oral presentations, and posters.
    • Hirsch Index of 20, indicating a significant impact on the scientific community.
    • Expertise in cutting-edge forensic and genetic technologies, including PCR, SNP analysis, and DNA sequencing.
  3. Pioneering Work in Forensic Science and Genetics:
    • Specializes in human remains identification, ancient DNA (aDNA) research, and non-destructive DNA extraction methods.
    • Innovations in seroanthropology and forensic ballistics, including DNA deposits on weapons, cases, and bullets.
    • Contributions to paternity testing and biological trace investigations.
  4. Legacy and Knowledge Sharing:
    • Continuation of professional contributions post-retirement by organizing a Museum of Medicine and Hospital Museum.
    • A mentor and guide to the next generation of researchers in the Molecular Techniques Unit.
  5. Interdisciplinary Research Interests:
    • Combines molecular genetics with medical diagnostics, forensic ballistics, and even museology, showcasing a holistic and diverse approach to science.

Education 🎓

  • 1963: Graduated from Primary School.
  • 1967: Completed High School.
  • 1971: Earned a degree in Biochemistry from the University of Wrocław.
  • 1977: Achieved a Ph.D. in Immunology.
  • 2001: Obtained Habilitation in Medical Genetics.
  • 2007: Awarded the title of University Professor in Medical Science.

Experience 💼

Tadeusz Dobosz’s career spans diverse roles in biochemistry, immunology, and forensic science:

  • 1971-1974: Ph.D. student and Assistant at the Polish Academy of Sciences.
  • 1975: Expert in the Police Laboratory of Criminalistics.
  • 1979: Lecturer at the Medical University, Department of Forensic Medicine, Wrocław.
  • 2002: Senior Lecturer at the Medical University of Wrocław.
  • 2004-2020: Head of the Molecular Techniques Unit, leading four specialized laboratories in Molecular Medicine, Paternity Testing, Forensic Genetics, and Seroanthropology.
  • 2020: Retired and now actively organizes the Museum of Medicine.

Research Interests 🔬

Professor Dobosz specializes in:

  • Forensic genetics and human remains identification.
  • Ancient DNA (aDNA) preparation, repair, and testing.
  • Non-destructive DNA isolation methods from valuable specimens.
  • DNA computing and forensic ballistics (e.g., DNA traces on weapons and bullets).
    Additionally, he has a keen interest in medical diagnostics using PCR and museology in medicine.

Awards and Recognition 🏆

Although specific awards are not listed, Professor Dobosz’s prolific contributions to molecular genetics and forensic science have established him as a leader in his field. His Hirsch Index of 20 underscores the impact of his work in the scientific community.

Publications 📚

  • “PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments”
    • Authors: Skoczyńska, A.; Ołdakowska, M.; Dobosz, A.; Małodobra-Mazur, M.; Dobosz, T.
    • Year: 2024
    • Citations: 1
  • “DNA Content of Various Fluids and Tissues of the Human Body”
    • Authors: Siuta, J.; Dobosz, A.; Kawecki, J.; Dobosz, T.
    • Year: 2024
    • Citations: 2
  • “The hero of American and Polish nations: a molecular look at Thaddeus Kosciuszko’s cause of death suggests a contribution of endocarditis caused by Cutibacterium acnes infection”
    • Authors: Witt, M.; Tokarski, M.; Ziętkiewicz, E.; Jurek, T.; Dobosz, T.
    • Year: 2022
    • Citations: 0
  • “Analysis of polymorphism in 11 STR markers in the European red deer (Cervus elaphus) population in Poland”
    • Authors: Jonkisz, A.; Lebioda, A.; Cierzniak, A.; Dobosz, T.; Małodobra-Mazur, M.
    • Year: 2022
    • Citations: 0
  • “Inheritance vs. infectivity as a mechanism of malady and death of Frederic Chopin”
    • Authors: Witt, M.; Dobosz, T.
    • Year: 2021
    • Citations: 3
  • “Histone modifications influence the insulin-signaling genes and are related to insulin resistance in human adipocytes”
    • Authors: Małodobra-Mazur, M.; Cierzniak, A.; Myszczyszyn, A.; Kaliszewski, K.; Dobosz, T.
    • Year: 2021
    • Citations: 12
  • “PpMolecular Medicinearg hypermethylation as the first epigenetic modification in newly onset insulin resistance in human adipocytes”
    • Authors: Małodobra-Mazur, M.; Cierzniak, A.; Kaliszewski, K.; Dobosz, T.
    • Year: 2021
    • Citations: 15
  • “DNA methylation in adipocytes from visceral and subcutaneous adipose tissue influences insulin-signaling gene expression in obese individuals”
    • Authors: Cierzniak, A.; Pawelka, D.; Kaliszewski, K.; Dobosz, T.; Małodobra-Mazur, M.
    • Year: 2021
    • Citations: 12
  • “Original and generic clopidogrel: A comparison of antiplatelet effects and active metabolite concentrations in patients without polymorphisms in the ABCB1 gene and the allele variants CYPC192 and 3″
    • Authors: Wójcik, T.; Szymkiewicz, P.; Ściborski, K.; Jonkisz, A.; Protasiewicz, M.
    • Year: 2021
    • Citations: 2
  • “Metabolic differences between subcutaneous and visceral adipocytes differentiated with an excess of saturated and monounsaturated fatty acids”
    • Authors: Małodobra-Mazur, M.; Cierzniak, A.; Pawełka, D.; Rudnicki, J.; Dobosz, T.
    • Year: 2020
    • Citations: 27

Conclusion ✨

Tadeusz Dobosz has left an indelible mark on forensic science, molecular biology, and medical genetics. From pioneering DNA sequencing techniques to advancing paternity testing and forensic genetics, his work has significantly impacted these fields. Even in retirement, his passion for medicine and science continues through his dedication to museology, ensuring that future generations benefit from his expertise and vision.